Monitoring and Self-management of Sleep Fatigue and Dyspnea
Heart Failure Patients
About this trial
This is an interventional device feasibility trial for Heart Failure Patients focused on measuring Heart failure, African Americans, Wrist worn device, Mixed- method
Eligibility Criteria
Inclusion Criteria
- Age 30-85years.
- Diagnosis of heart failure based on patient's medical record.
- Meets the criteria for New York Heart Failure (NYHF) classification for stage I-III heart failure.
- Meets the criteria for ACA/AHA HF classification Stage A and B (Patient with clinical HF).
Exclusion Criteria
- Exclusion criteria include patients with a diagnosis of dementia, patients on the heart transplant
- list and stage IV HF.
Sites / Locations
- University of Massachusetts AmherstRecruiting
Arms of the Study
Arm 1
Other
Feasibility of Wearing a Readiband
Participants will wear the Fatigue Science Readiband for 42 consecutive day. On day one, every seventh day and at the end of the study each participant will complete the Dyspnea-Characteristic scale, BRICS NINR PROMIS Fatigue Short Form6a scale , Modified Pulmonary Functional Status, Dyspnea Questionnaire and the BRICS NINR PROMIS SF v1.0-Sleep Disturbance 6a scale.The Minnesota Living with Heart Failure Questionnaire and Self-Care of Heart Failure Index will be completed on day one and day 60. The purpose of this intervention is to assess the Feasibility of Wearing a Readiband. Semi-structured Interview will be conducted at the end of 42 days to assess patient comfort and challenges with wearing the Readiband.